NRBP2 Functions as a Tumor Suppressor and Inhibits Epithelial-to-Mesenchymal Transition in Breast Cancer
Zhiyu Li(Wuhan University), Xiongjie Zhang(East China University of Technology)
Cited by 7
Related Papers
MEDAG enhances breast cancer progression and reduces epirubicin sensitivity through the AKT/AMPK/mTOR pathway
|Cell Death and Disease|2021|32